Is DMT Legal? Psychedelics and the Law

Lauren Smith
Dr. Celeste Small
Written by Lauren Smith on 23 August 2022
Medically reviewed by Dr. Celeste Small on 05 November 2024

DMT is a controlled substance in the US under the federal Controlled Substance Act (1971), making it illegal to manufacture, distribute, buy, or possess DMT. However, DMT can be researched for medical use in approved studies, DMT-containing brews have been authorized for religious use by some churches with origins in South America, and one state and a handful of cities have decriminalized it alongside other psychedelics.

Key takeaways:
  • DMT use is not legal in the United States, but some religious groups have been granted exemptions from the Controlled Substances Act to import and consume DMT-containing ayahuasca for sacramental reasons.
  • With a growing interest in the potential therapeutic application of DMT, researchers and drug developers can request for authorization to study it, subject to the approval of the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA). DMT still has no approved medicinal use in the US currently.
  • Some cities and states approved legislative measures to eliminate criminal penalties for the possession and/or use of DMT and similar psychedelics.
Glass containing red liquid with bark, root, and green leaves.

Is DMT a controlled substance?

Under United States federal law, DMT (N, N-dimethyltryptamine) is a schedule I controlled substance, making it illegal to manufacture, distribute, buy, or possess.

However, there are some instances where DMT use is decriminalized or exemptions are provided.

  • Decriminalization in some cities or states. In recent years some US jurisdictions have passed or are considering legislation decriminalizing DMT and other psychedelics. Decriminalization is different than legalization: DMT remains illegal across the country. However, some cities and states have opted to remove or deprioritize criminal penalties for DMT and other psychedelics, usually for personal and non-commercial use and in small quantities. Employers and other authorities may still ask for people to provide a DMT drug test in some instances.
  • Medical and clinical research authorizations. Researchers can also apply to the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA) to study and conduct trials with DMT.
  • Religious exemptions. Some religious groups have been granted exemptions from the Controlled Substances Act to import and consume DMT-containing ayahuasca for sacramental reasons.

Decriminalization of psychedelics in states and cities

A few states and cities have implemented laws in their jurisdiction to allow more accessibility to psychedelic drugs. There has been a surge of interest in the drug’s application in different areas of the country.

State-level decriminalization of psychedelics

The following states have currently decriminalized psychedelic use.

California, Maine, and Vermont are now also moving to decriminalize DMT, while Missouri is considering legalizing it for therapeutic use.

City-level decriminalization of psychedelics

In 2019, the California city of Oakland became the first jurisdiction in the US to decriminalize a range of psychedelics, including DMT and ayahuasca. Since then, about two dozen cities in the country have followed suit, including:

  • Santa Cruz, California
  • Denver, Colorado
  • Cambridge, Massachusetts
  • Somerville, Massachusetts
  • Ann Arbor, Michigan
  • Seattle, Washington
  • Washington DC

What is a schedule I substance?

Schedule I substances are drugs thought to have a high chance of being abused or causing addiction and have no FDA-approved medicinal use in the US. The scheduling system was created by the Controlled Substances Act in 1971, sorting drugs into Schedules I through V.

  • Schedule I drugs include heroin, cannabis, ecstasy, and most psychedelics.
Controversy surrounding psychedelics and its schedule I classification

Some people assume that substances are scheduled based on their potential for harm to the individual and society and are baffled to hear that cannabis and psychedelics are schedule I while opioid painkillers and cocaine are schedule II. This confusion reflects how much our attitudes to some drugs have changed in the 50 years since the Controlled Substances Act was enacted.

  • In the backlash against the hippie movement of the 1960s, people believed psychedelics and hallucinogens were eroding the very fabric of society and classified as highly dangerous. Although research now suggests that psychedelics have a low potential for addiction and may even be a powerful treatment for it and other mental health conditions, their scheduling remains unchanged. There is a push from scientists to downgrade these drugs to schedule III, which would enable more research into their therapeutic use.
  • Scheduling also accounts for a drug’s recognized, mainstream medicinal value as much as its potential for abuse. Despite their addictive potential, opioid painkillers and cocaine have long accepted medical use—for pain relief and as an aesthetic, respectively—therefore are schedule II. The medical uses of cannabis and especially psychedelics have been less well documented and in many cases are still being explored.
  • Additionally, while criminal laws and punishments do reflect the scheduling system, they also take other things into account, particularly in the hands of open-minded prosecutors. Cannabis and psychedelics being schedule I also haven’t prevented some jurisdictions from decriminalizing them.

Related blog: Psychedelic Compound DMT Increases Connectivity In The Brain, Scans Reveal

When was DMT made a schedule I substance?

DMT was made a schedule I substance when the Controlled Substances Act came into effect in 1971.

Internationally, DMT is a Schedule I controlled substance under the United Nations' 1971 Convention on Psychotropic Substances. Therefore, use is supposed to be restricted to scientific research and medicine, and trade is closely monitored. There is no country in the world where DMT itself is legal in whatever form it is taken.

However, organic materials containing DMT and the ayahuasca brew aren’t regulated under the Convention on Psychotropic Drugs. They're legal in some countries, primarily in South America where most DMT-containing plants grow and indigenous peoples have long histories of using them for religious purposes.

Legality covers a wide range of possibilities: in some places ayahuasca is specifically legal (for example, Peru), while in others there’s simply no legislation specifically barring it (for example in Argentina).

Ayahuasca can be considered at least partly legal or at least not specifically illegal, in:

  • Argentina
  • Bolivia
  • Brazil
  • Columbia
  • Ecuador
  • Mexico
  • Peru:
  • Portugal: as part of its general decriminalization of the possession and personal use of all drugs in 2001. Transportation and cultivation remain criminal offenses.

For more information about the often ambiguous legal status of ayahuasca around the world, see the Ayahuasca Defense Fund’s country by country map.

While DMT currently has no approved medicinal use in the US, researchers and drug developers are permitted to study it, subject to the approval of the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA). Schedule I drugs are the most difficult to gain authorization to research however, clinical trials have been approved and are ongoing in the US.

Worldwide, DMT is being investigated for its therapeutic potential for the following conditions with promising results: 

  • Treatment-resistant depression
  • Parkinson’s disease
  • Vision loss
  • Addiction

Outside of authorized trials, DMT therapy is illegal in the US and conducted only in underground clinics. However, with many predicting the laws around DMT for therapeutic use to change, big pharma companies have already started applying for patents for DMT vape pens, a move that could make receiving treatment unaffordable for many.

Can DMT be used in a religious context?

DMT-containing plants and brews have an important sacramental role in the religions of some indigenous peoples from the Amazon Basin. US legislation and courts have enumerated exemptions to the Controlled Substances Act for the religious use of otherwise prohibited psychedelic drugs, including DMT and bufo DMT, also known as toad venom or 5-MeO DMT.

In 2006, the Supreme Court unanimously ruled that under the 1993 Religious Freedom Restoration Act, the federal government had to permit the Brazil-based União do Vegetal (UDV) church to import and consume DMT-containing tea for sacramental use. A few years later, three US-based Santo Daime churches were also granted approval to use ayahuasca.

Following the UDV case, the Drug Enforcement Administration (DEA) issued interim guidelines requiring religious groups to apply for exemptions to the Controlled Substances Act and to demonstrate they hold sincere religious beliefs.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Asmelash, L., & Ahmed, S. (2019, June 5). Oakland decriminalizes magic mushrooms and other psychedelic drugs. CNN.
  2. Fuller, T. (2020, December 2). Oregon Decriminalizes Small Amounts of Heroin and Cocaine; Four States Legalize Marijuana. The New York Times.
  3. Psychedelics Legalization & Decriminalization Tracker. (2022). Psychedelic Alpha. https://psychedelicalpha.com/data/psychedelic-laws
  4. Marks, M. (2021, October 11). A Strategy for Rescheduling Psilocybin. Scientific American.
  5. International Center for Ethnobotanical Education, Research, and Service (ICEERS) & The Ayhuasca Defense Fund. (2020, July 1). Country-by-Country: Legal Status Map.
  6. Jarvie, E. (2022, February 17). The Latest in DMT Research: Leading Companies and Key Studies. Truffle Report.
  7. Thorne, G. (2022, August 19). Religious Use of Psychedelic Drugs Under Federal Law: A History. Harris Bricken.

Activity History - Last updated: 05 November 2024, Published date:


Reviewer

Dr. Celeste Small

Pharm.D, RPh.

Celeste Small, PharmD. is a licensed and practicing pharmacist and medical writer who specializes in different substances, the effects of substance abuse, and substance use disorder.

Activity History - Medically Reviewed on 15 December 2022 and last checked on 05 November 2024

Medically reviewed by
Dr. Celeste Small

Pharm.D, RPh.

Dr. Celeste Small

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (855) 648-7288
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

For any specific questions please email us at info@recovered.org

More on DMT